补肾健脾涤痰逐瘀汤联合西药治疗肥胖型多囊卵巢综合征临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R711.75;R271.1

基金项目:


Clinical Study on Bushen Jianpi Ditan Zhuyu Decoction Combined with Western Medicine for Polycystic Ovary Syndrome of Obesity Type
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察补肾健脾涤痰逐瘀汤联合西药治疗肥胖型多囊卵巢综合征(PCOS) 的临床疗效。方 法:选取2022年10月—2023年10月在信阳市中医院治疗的84例肥胖型PCOS患者。按随机数字表法分为观察 组与对照组各42例。对照组予以西药(盐酸二甲双胍缓释片加炔雌醇环丙孕酮片) 治疗,观察组在对照组基 础上给予补肾健脾涤痰逐瘀汤治疗。2组均治疗3个月经周期。比较2组治疗前后中医证候积分、脂代谢指标 [甘油三酯(TG)、总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C) 水平]、 体质量指数(BMI)、胰岛素抵抗指数(HOMA-IR)、性激素[睾酮(T)、卵泡刺激素(FSH)、黄体生成 素(LH) 及LH/FSH比值] 和卵巢多囊样状态[卵泡数、最大卵泡直径及卵巢体积],治疗后随访3个月评定 临床疗效。结果:治疗后,2 组中医证候积分均较治疗前降低(P<0.05),观察组中医证候积分低于对照 组(P<0.05)。2组TG、TC、LDL-C水平,HOMA-IR,以及BMI值均较治疗前降低(P<0.05),观察组TG、 TC、LDL-C水平,HOMA-IR,以及BMI值均低于对照组(P<0.05)。2组HDL-C水平均较治疗前升高(P< 0.05),观察组HDL-C水平高于对照组(P<0.05)。2组血清T、LH水平及LH/FSH比值均较治疗前降低(P< 0.05),观察组血清T、LH 水平及LH/FSH 比值均低于对照组(P<0.05)。2组卵泡数均较治疗前减少(P< 0.05),最大卵泡直径均较治疗前增大(P<0.05),卵巢体积均较治疗前缩小(P<0.05);观察组卵泡数少于对 照组(P<0.05),最大卵泡直径大于对照组(P<0.05),卵巢体积小于对照组(P<0.05)。治疗后随访3个月, 总有效率观察组87.50%(35/40),高于对照组67.50%(27/40)(P<0.05)。结论:与单纯使用西药治疗比较, 补肾健脾涤痰逐瘀汤联合西药治疗肥胖型PCOS可提升疗效,有效缓解临床症状,减轻体质量,调节血脂和性 激素水平,改善卵巢多囊样状态。

    Abstract:

    Abstract: Objective: To observe the clinical effect of Bushen Jianpi Ditan Zhuyu Decoction combined with western medicine for polycystic ovary syndrome(PCOS) of obesity type. Methods: A total of 84 PCOS patients of obesity type treated at Traditional Chinese Medicine Hospital of Xinyang from October 2022 to October 2023 were selected and divided into the observation group and the control group using a random number table method, with 42 cases in each group. The control group was treated with western medicine (Metformin Hydrochloride Sustained- Release Tablets and Ethinyl-estradiol Cyproterone Acetate Tablets), while the observation group was treated with Bushen Jianpi Ditan Zhuyu Decoction on the basis of the control group. Both groups were treated for three menstrual cycles. Compared the traditional Chinese medicine (TCM) syndrome scores, lipid metabolism indicators [triglycerides (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C) levels],body mass index (BMI),homeostasis model assessment of insulin resistance index (HOMA-IR) , sex hormones [testosterone (T) , follicle stimulating hormone (FSH) , luteinizing hormone (LH),and LH/FSH ratio],and polycystic ovary status (follicle number,maximum follicle diameter,and ovarian volume) before and after treatment between the two groups. Patients were followed up for three months after treatment to assess the clinical effects. Results: The TCM syndrome scores in both groups were decreased when compared with those before treatment (P<0.05),and the TCM syndrome scores in the observation group were lower than those in the control group (P<0.05). The levels of TG,TC,LDL-C,HOMA-IR,and BMI in both groups were decreased when compared with those before treatment (P<0.05),and the levels of TG,TC,LDL-C,HOMA-IR, and BMI in the observation group were lower than those in the control group (P<0.05). Both groups showed an increase in HDL-C levels when compared with those before treatment (P<0.05), with the observation group having a higher HDL-C level than the control group (P<0.05). The levels of serum T, LH, and LH/FSH ratio in both groups were decreased when compared with those before treatment (P<0.05),and the levels of serum T,LH,and LH/FSH ratio in the observation group were lower than those in the control group (P<0.05). The number of follicles in both groups were decreased when compared with those before treatment (P<0.05),the maximum follicle diameter was increased when compared with that before treatment (P<0.05),and the ovarian volume was decreased when compared with that before treatment (P<0.05); the observation group had fewer follicles than the control group (P<0.05), a larger maximum follicle diameter than the control group (P<0.05),and a smaller ovarian volume than the control group (P< 0.05). Follow up for three months after treatment,the total effective rate was 87.50% (35/40) in the observation group, which was higher than that of 67.50% (27/40) in the control group (P<0.05). Conclusion:Compared with the use of western medicine alone,the combination of Bushen Jianpi Ditan Zhuyu Decoction and western medicine can improve the efficacy of treating PCOS of obesity type, effectively alleviate clinical symptoms, reduce body weight, regulate blood lipids and sex hormone levels,and improve polycystic ovary syndrome.

    参考文献
    相似文献
    引证文献
引用本文

袁海晨,杨春,易磊,邹严.补肾健脾涤痰逐瘀汤联合西药治疗肥胖型多囊卵巢综合征临床研究[J].新中医,2025,57(6):57-63

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2025-03-26
  • 出版日期:
文章二维码